QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ONC

QT54BeOne Medicines Ltd.
NASDAQ·Healthcare·Medical - Pharmaceuticals·USA
Latest market price
270.15
+7.47+2.84%
OverviewShort InterestFilings
ONCQT54BeOne Medicines Ltd.·NASDAQ
OverviewShort InterestFilings
270.15+2.84%
TA
Loading chart...
Screen all →
AVLN+7.30%$31.45CGEM+4.09%$15.03LLY-1.21%$1098.57JNJ-2.48%$228.39ABBV-2.08%$216.63UNH+0.36%$400.96NVS-2.52%$147.08MRK-1.36%$113.87
Snapshot
Index-P/E90.23EPS (ttm)46.47
Insider Own1.67%
Shs Outstand1.54B
Perf Week3.80%
Market Cap33.71BForward P/E28.11EPS next Y9.61Insider Trans0.00%Shs Float-Perf Month-9.04%
Enterprise Value30.92BPEG0.18EPS next Q1.65Inst Own-Short Float-Perf Quarter-4.45%
Income374.18MP/S5.84EPS this Y-85.52%Inst Trans-Short Ratio-Perf Half Y-11.23%
Sales5.77BP/B9.73EPS next Y42.77%ROA6.00%Short Interest-Perf YTD-11.08%
Book/sh3.09P/C35.96EPS next 5Y30.61%ROE12.10%52W High385.21 -29.87%Perf Year6.32%
Cash/sh3.11P/FCF30.58EPS past 3/5Y-ROIC7.82%52W Low239.24 12.92%Perf 3Y-
Dividend Est.-EV/EBITDA36.72Sales past 3/5Y55.68% 76.83%Gross Margin87.17%Volatility2.19% 2.10%Perf 5Y-
Dividend TTM-EV/Sales5.36EPS Y/Y TTM173.04%Oper. Margin11.96%ATR (14)8.24Perf 10Y-
Dividend Ex-Date-Quick Ratio3.27Sales Y/Y TTM50.60%Profit Margin8.93%RSI (14)41.11Recom2.11
Dividend Gr. 3/5Y-Current Ratio3.64EPS Q/Q60.66%SMA20-3.11%Beta0.79Target Price399.11
Payout0.00%Debt/Eq0.43Sales Q/Q35.45%SMA50-8.59%Rel Volume1.30Prev Close262.68
Employees11,000LT Debt/Eq0.43EarningsAug 05SMA200-15.14%Avg Volume249.17KPrice270.15
IPO DateFeb 02, 2016Option/ShortYes / YesEPS/Sales Surpr.168.49% 2.51%Net Debt/EBITDA-3.31Volume323,566Change2.84%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-02-26ReiteratedRBC CapitalOutperform$425 → $436
May-15-26ReiteratedLeerink PartnersOutperform$367
May-07-26ReiteratedMorgan StanleyOverweight$389 → $395
May-07-26ReiteratedGuggenheimBuy$420
May-07-26ReiteratedBarclaysOverweight$394 → $409
May-04-26InitiatedWells FargoOverweight$400
Apr-08-26ReiteratedTruist Financial$412 → $411
Mar-26-26InitiatedWolfe ResearchOutperform$340
Mar-16-26DowngradeJefferiesBuy → Hold
Feb-04-26ReiteratedBarclaysOverweight$385 → $394
Latest News
Jun-16-26
Jun-16-2611:02AM
Chief Executive Officer Of BeOne Medicines Makes $501K SaleBenzinga
11:02AM
Sell Alert: Henry Chan Lee Cashes Out $110K In BeOne Medicines StockBenzinga
11:02AM
Xiaobin Wu Executes Sell Order: Offloads $163K In BeOne Medicines StockBenzinga
11:02AM
Insider Transaction: Aaron Rosenberg Sells $162K Worth Of BeOne Medicines SharesBenzinga
11:02AM
BeOne Medicines President Trades $197K In Company StockBenzinga
Jun-11-26
Jun-11-2611:30AM
Here's How Much You Would Have Made Owning BeOne Medicines Stock In The Last 10 YearsBenzinga
11:30AM
Here's How Much You Would Have Made Owning BeOne Medicines Stock In The Last 10 YearsBenzinga
11:02AM
Insider Unloading: JOHN OYLER Sells $1.34M Worth Of BeOne Medicines SharesBenzinga
11:02AM
Insider Unloading: JOHN OYLER Sells $1.34M Worth Of BeOne Medicines SharesBenzinga
11:02AM
Insider Decision: Xiaobin Wu Offloads $399K Worth Of BeOne Medicines StockBenzinga
11:02AM
Insider Decision: Xiaobin Wu Offloads $399K Worth Of BeOne Medicines StockBenzinga
11:02AM
BeOne Medicines President Trades $368K In Company StockBenzinga
11:02AM
BeOne Medicines President Trades $368K In Company StockBenzinga
11:02AM
Insider Unloading: Henry Chan Lee Sells $235K Worth Of BeOne Medicines SharesBenzinga
11:02AM
Insider Unloading: Henry Chan Lee Sells $235K Worth Of BeOne Medicines SharesBenzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue5,7385,3433,810
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A671669594
Gross Profit5,0694,6743,216
Selling, General and Administrative Excl. Other2,1772,0811,831
Research and Development2,2052,1461,953
Other Operating Expense100
Operating Income686447-568
Interest Expense33580
Unusual Expense
———
Non-Operating Income (Expense)-66-28-35
Net Income Before Taxes655417-533
Income Taxes142130112
Consolidated Net Income513287-645
Net Income From Continuing Operations513287-645
Net Income513287-645
EPS (Recurring)49.8833.80-6.12
EPS (Basic, Before Extraordinaries)49.8833.80-6.12
EPS (Diluted)46.4732.11-6.12
EBITDA901617-361
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio5.819.46—
Price To Sales Ratio5.236.20—
Gross Margin88.3487.4884.41
Operating Margin11.968.37-14.91
Net Margin8.945.37-16.93
Shares Outstanding111109105
Market Capitalization29,98733,115—
Operating Lease Expense
———
Insider Trading Volume
$293.34$272.63$251.92$231.22$210.51● Close Price0.00M7.75M15.50M23.25M31.00MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Wang LaiPresident, Global Head of R&DJun 11 '26Sale261.00756197,3180Jun 15 12:00 AM
Ball Titus B.Principal Accounting OfficerJun 11 '26Sale257.2016943,4670Jun 15 12:00 AM
Rosenberg AaronChief Financial OfficerJun 11 '26Sale257.74631162,6370Jun 15 12:00 AM
Wu XiaobinPresident and COOJun 11 '26Sale261.20626163,5120Jun 15 12:00 AM
Lee Chan HenrySVP, General CounselJun 11 '26Sale257.63428110,2680Jun 15 12:00 AM
OYLER JOHNChief Executive OfficerJun 11 '26Sale257.241,949501,3550Jun 15 12:00 AM
Ball Titus B.Principal Accounting OfficerJun 08 '26Sale271.3313636,9010Jun 10 12:00 AM
Lee Chan HenrySVP, General CounselJun 08 '26Sale270.42871235,5390Jun 10 12:00 AM
Wang LaiPresident, Global Head of R&DJun 08 '26Sale269.381,367368,2470Jun 10 12:00 AM
Wu XiaobinPresident and COOJun 08 '26Sale269.371,484399,7380Jun 10 12:00 AM
OYLER JOHNChief Executive OfficerJun 08 '26Sale270.564,9401,336,5480Jun 10 12:00 AM
Riva AlessandroDirectorMay 22 '26Sale309.5121265,6170May 27 12:00 AM
Dugan MargaretDirectorMay 22 '26Sale309.6021265,6360May 27 12:00 AM
Sanders Corazon (Corsee) D.DirectorMay 22 '26Sale309.5921265,6330May 27 12:00 AM
BAKER BROS. ADVISORS LPDirectorMay 22 '26Sale23.8210,998261,982142,566May 27 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR